Co-founder of VydaMed had severe anxiety disorder as a child. This experience led to the creation of VydaMed, Inc
VydaMed is developing a non-invasive targeted treatment for the control of anxiety and mood disorders. Our technology utilizes closed-loop control to regulate the relaxation / alertness equilibrium and a measurable reduction in anxiety.
Safe wearable and Smartphone app. Wearable calms the nervous system extrinsically, while app displays heart rate variability statistics showing when and why the user had a panic attack. App comes with guided therapy techniques to create intrinsic positive thought patterns.
Will be available in the US once it is developed, tested and FDA-approved
Amidst an unprecedented surge in anxiety levels across the US, the nation has earned the unenviable title of the most anxious country worldwide, with no sign of abatement. The severity of this issue becomes evident when considering that one in eight children are affected by anxiety disorders, with a prevalence of severe anxiety disorder reaching 5.9% over their lifetime.
Anxiety manifests in diverse and distressing forms, with Generalized Anxiety Disorder being the most prevalent diagnosis. Its symptoms span from mild discomforts to life-threatening situations, affecting individuals both physically and psychologically.
While therapy stands as a viable solution, it may not always be accessible or ideal. The cost of therapy, whether through private or public practices, often becomes a barrier, and the overwhelming demand for treatment has led to a shortage of available practitioners. Moreover, finding the right therapist, with whom patients can form a meaningful connection, presents challenges. The limited frequency of therapy sessions, typically occurring biweekly, makes it challenging to address anxiety in real-time when not in treatment.
Despite the merits of therapy and prescription medications for long-term healing, there exists an urgent need for immediate interventions to manage anxiety in the moment. The development of effective real-time interventions, Such as VydaMed’s wearable , could provide individuals with much-needed relief and support during acute episodes, supplementing traditional approaches for a comprehensive and holistic approach to anxiety management.
VydaMed’s cutting-edge non-invasive neuromodulation device will revolutionize anxiety management by regulating the release of stress hormones in the body, including epinephrine and cortisol. The key focus is on activating the parasympathetic autonomic nervous system, achieved through a sophisticated closed-loop feedback system that continuously monitors stress-related vital signs and responds by stimulating the Vagus Nerve, a pivotal branch of the parasympathetic nervous system. Notably, the Company’s device empowers users with complete control over the initiation and termination of treatment.